Detection and quantitation of perlecan mRNA levels in Alzheimer's disease and normal aged hippocampus by competitive reverse transcription- polymerase chain reaction

Journal of Neurochemistry

Volumn 67, Issue 3, 1996, Pages 1132-1144

  Maresh, Grace A ^a   Erezyilmaz, Deniz ^a   Murry, Charles E ^a   Nochlin, David ^a   Snow, Alan D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alzheimer's disease; Expression; Heparan sulfate; Perlecan; Proteoglycans; Reverse transcription polymerase chain reaction

Indexed keywords

AMYLOID BETA PROTEIN; MESSENGER RNA; PERLECAN; PROTEOHEPARAN SULFATE;

AGING; ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENILE PLAQUE;

ANIMALIA; RODENTIA;

EID: 0029820953     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67031132.x     Document Type: Article

References (86)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501.
2. Ailles L., Kisilevsky R., and Young I. D. (1993) Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis. Lab. Invest. 69, 443-447.
3. Branden K. R., Richter-Cook N. J., Chaturvedi N., and Frederickson R. C. A. (1993) pH-dependent binding of synthetic β-amyloid peptides to glycosaminoglycans. J. Neurochem. 61, 2147-2154.
4. Buee L., Ding W., Anderson J. P., Narindrasorasak S., Kisilevsky R., Boyle N. J., Robakis N. K., Delacourte A., Greenberg B., and Fillit H. M. (1993a) Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Res. 627, 199-204.
5. Buee L., Ding W., Delacourte A., and Fillit H. (1993b) Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. Brain Res. 601, 154-163.
6. Cardin A. D. and Weintraub H. J. R. (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9, 21-32.
7. Carpenter A. F., Carpenter P. W., and Markesbery W. R. (1993) Morphometric analysis of microglia in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 52, 601-608.
8. Chakravarti S., Phillips S. L., and Hassell J. R. (1991) Assignment of the perlecan (heparan sulfate proteoglycan) gene to mouse chromosome 4. Mamm. Genome 1, 270-272.
9. Chakravarti S., Hassell J. R., and Phillips S. (1993) Perlecan gene expression precedes laminin gene expression during differentiation of F9 embryonal carcinoma cells. Dev. Dyn. 197, 107-114.
10. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
11. Cohen I. R., Grassel S., Murdoch A. D., and Iozzo R. V. (1993) Structural characterization of the complete human perlecan gene and its promoter. Proc. Natl. Acad. Sci. USA 90, 10404-10408.
12. Coleman P. D. and Flood D. G. (1987) Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol. Aging 8, 521-545.
13. Coria F., Castano E., Prelli F, Lillo-Larrondo M., Van Duinen S., Shelanski M. L., and Frangione B. (1988) Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidoses. Lab. Invest. 58, 454-458.
14. DeWitt D. A., Silver J., Canning D. R., and Perry G. (1993) Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease. Exp. Neurol. 121, 149-152.
15. Dodge G. R., Kovalsky I., Chu M. L., Hassell J. R., McBride O. W., Yi H. F., and Iozzo R. (1991) Heparan sulfate proteoglycan of human colon: partial molecular cloning, cellular expression, and mapping of the gene (HSPG2) to the short arm of human chromosome 1. Genomics 10, 673-680.
16. Dodge G. R., Boesler E. W., and Jimenez S. A. (1995) Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells. Lab. Invest. 73, 649-657.
17. Doege K. J., Sasaki M., Kimurai T., and Yamada Y. (1991) Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. J. Biol. Chem. 266, 894-902.
18. Dours-Zimmerman M. T. and Zimmerman D. R. (1994) A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J. Biol. Chem. 269, 32992-32998.
19. Eikelenboom P., Hack C. E., Rozemuller J. M., and Stam F. C. (1989) Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch. B Cell Pathol. 56, 259-262.
20. Fraser P. E., Nguyen J. T., Chin D. T., and Kirschner D. A. (1992) Effect of sulfate ions on Alzheimer β/A4 assemblies: implications for amyloid fibril-proteoglycan interactions. J. Neurochem. 59, 1531-1540.
21. Gilliland G., Perrin S., Blanchard K., and Bunn H. F. (1990) Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87, 2725-2729.
22. Glenner G. G. and Wong C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
23. Grover J. and Roughley P. J. (1993) Versican gene expression in human articular cartilage and comparison of mRNA splicing variation with aggrecan. Biochem. J. 291, 361-367.
24. Grundke-Iqbal I., Iqbal K., Tung Y., Quinlan M., Wisniewski H. M., and Binder L. I. (1986) Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83, 4913-4917.
25. Gupta-Bansal R., Frederickson R. C. A., and Brunden K. R. (1995) Proteoglycan-mediated inhibition of Aβ proteolysis. J. Biol. Chem. 270, 18666-18671.
26. Hefti F. and Weiner W. J. (1986) Nerve growth factor and Alzheimer's disease. Ann. Neurol. 20, 275-281.
27. Hefti F., Hartikka J., and Knusel B. (1989) Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol. Aging 10, 515-533.
28. Husby G., Araki S., Benditt E. P., Benson M. D., Cohen A. S., Frangione B., Glenner G. G., Natvig J. B., and Westermark P. (1993) Nomenclature of amyloid and amyloidosis. Bull. WHO 71, 105-108.
29. Ito K., Shinomura T., Zako M., Ujita M., and Kimata K. (1995) Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J. Biol. Chem. 270, 958-965.
30. Kallunki P. and Tryggvason K. (1992) Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Cell Biol. 116, 559-571.
31. Kallunki P., Eddy R. L., Byers M. G., Kestila M., Shows T. B., and Tryggvason K. (1991) Cloning of human heparan sulfate proteoglycan core protein, assignment of the gene (HSPG2) to Ip36.1-p35 and identification of a BamHI restriction fragment length polymorphism. Genomics 11, 389-396.
32. Kato M., Koike Y., Suzuki S., and Kimata K. (1988) Basement membrane proteoglycan in various tissues: characterization using monoclonal to the Engelbreth-Holm-Swarm mouse tumor low density heparan sulfate proteoglycan. J. Cell Biol. 106, 2203-2210.
33. Kato T., Sasaki H., Katagiri T., Koiwai K., Youki H., Totsuka S., and Ishii T. (1991) The binding of bFGF to Alzheimer's disease neurofibrillary tangles and senile plaques. Neuroscience 122, 33-36.
34. Kinsella M. G. and Wight T. N. (1988) Structural characterization of heparan sulfate proteoglycan subclasses isolated from bovine aortic endothelial cell cultures. Biochemistry 27, 2136-2144.
35. Kisilevsky R. and Snow A. D. (1988) The potential significance of sulphated glycosaminoglycans as a common constituent of all amyloids; or perhaps amyloid is not a misnomer. Med. Hypotheses 26, 231-236.
36. Kokenyesi R. and Silbert J. E. (1995) Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells. Biochem. Biophys. Res. Commun. 211, 262-267.
37. Kosik K. S., Joachim C. L., and Selkoe D. J. (1986) Microtubuleassociated protein tau is a major antigenic component of paired helical filaments in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 83, 4044-4048.
38. Lee V. M. Y., Balin B. J., Otvos L. Jr., and Trojanowski J. Q. (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251, 675-678.
39. Mackenzie I. R. A., Hao C., and Munoz D. G. (1995) Role of microglia in senile plaque formation. Neurobiology 16, 797-804.
40. Masters C. L., Simms G., Weinman N. A., Multhaup G., Donald B. L., and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
41. McCubbin W. D., Kay C. M., Narindrasorasak S., and Kisilevsky R. (1988) Circular-dichroism studies on two murine serum amyloid A proteins. Biochem. J. 256, 775-783.
42. McGeer P. L., Akiyama H., Hagaki S., and McGeer E. G. (1989) Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16, 516-527.
43. Mori H., Kondo J., and Ihara Y. (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235, 1641-1644.
44. Mountjoy C. Q., Roth M., Evans N. J. R., and Evans H. M. (1983) Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol. Aging 4, 1 -11.
45. Murdoch A. D., Dodge G. R., Cohen I., Tuan R. S., and Iozzo R. V. (1992) Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Biol. Chem. 267, 8544-8557.
46. Murdoch A. D., Liu B., Schwarting R., Tuan R. S., and Iozzo R. V. (1994) Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J. Histochem. Cytochem. 42, 239-249.
47. Murry C. E., Bartosek T., Giachelli C. M., Alpers C. E., and Schwartz S. M. (1996) PDGF-A mRNA expression in fetal, normal adult, and atherosclerotic human aortas. Analysis by competitive PCR. Circulation 93, 1095-1106.
48. Namba Y., Tomonaga M., Kawasaki H., Otomon E., and Ikeda K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541, 163-166.
49. Narindrasorasak S., Lowry D. E., Gonzalez-DeWhitt P. A., Poorman R. A., Greenberg B. D., and Kisilevsky R. (1991) High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. J. Biol. Chem. 266, 12878-12883.
50. Nochlin D., Mackenzie A. P., Bryant E. M., Norwood T. H., and Sumi S. M. (1993) A simple method of rapid freezing adequately preserves brain tissue for immunocytochemistry, light and electron microscopic examination. Acta Neuropathol (Berlin) 86, 645-650.
51. Noonan D. M. and Hassell J. R. (1993) Perlecan, the large low density proteoglycan of basement membranes: structure and variant forms. Kidney Int. 43, 53-60.
52. Noonan D. M., Fulle A., Valente P., Cai S., Horigan E., Sasaki M., Yamada Y., and Hassell J. R. (1991) The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J. Biol. Chem. 266, 22939-22947.
53. Perlmutter L. S. and Chui H. C. (1990) Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res. Bull. 24, 677-686.
54. Perlmutter L. S., Chui H. C., Saperia D., and Athanikar J. (1990) Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease. Brain Res. 508, 13-19.
55. Perry G., Freidman R., Shaw G., and Chau V. (1987) Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites in Alzheimer's disease brain. Proc. Natl. Acad. Sci. USA 84, 3033-3036.
56. Rescan P. Y., Loreal O., Hassell J. R., Yamada Y., Guillouzo A., and Clement B. (1993) Distribution and origin of the basement membrane component perlecan in rat liver and primary hepatocyte culture. Am. J. Pathol 142, 199-208.
57. Rogers J. (1994) Inflammation and Alzheimer's disease. CNS Drugs 4, 241-244.
58. Roher A. E., Palmer K. C., Yurewicz E. C., Ball M. J., and Greenberg B. D. (1993) Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer's disease brain tissue. J. Neurochem. 61, 1916-1926.
59. Saku T. and Furthmayr H. (1989) Characterization of the major heparan sulfate proteoglycan secreted by bovine aortic endothelial cells in culture. J. Biol. Chem. 264, 3514-3523.
60. Schechter R., Yen S. H. C., and Terry R. D. (1981) Fibrous astrocytes in senile dementia of the Alzheimer type. J. Neuropathol. Exp. Neurol. 40, 95-101.
61. Seber G. A. F. (1977) Linear Regression Analysis. John Wiley and Sons, New York.
62. Sekiguchi R. T., Potter-Perigo S., Braun K., Miller J., Ngo C., Fukuchi K., Wight T. N., Kimata K., and Snow A. D. (1994) Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation. J. Neurosci. Res. 38, 670-686.
63. Selkoe D. J. and Abraham C. (1986) Isolation of paired helical filaments and amyloid fibers from human brain. Methods Enzymol. 134, 388-404.
64. Snow A. D. and Wight T. N. (1989) Proteoglycans in the pathogenesis of Alzheimer's disease. Neurobiol. Aging 10, 481-497.
65. Snow A. D., Willmer J., and Kisilevsky R. (1987) Sulfated glycos-aminoglycans: a common constituent of all amyloids. Lab. Invest. 56, 120-123.
66. Snow A. D., Mar H., Nochlin D., Kimata K., Kato M., Suzuki S., Hassell J., and Wight T. N. (1988) The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy of Alzheimer's disease. Am. J. Pathol. 133, 456-463.
67. Snow A. D., Kinsella M. G., Prather P. B., Nochlin D., Podlisny M. B., Selkoe D. J., Kisilevsky R., Hassell J. R., and Wight T. N. (1989) A characteristic binding affinity between heparan sulfate proteoglycans and the A4 amyloid protein of Alzheimer's disease (Abstr.). J. Neuropathol. Exp. Neurol. 48, 352.
68. Snow A. D., Mar H., Nochlin D., Sekiguchi R. T., Kimata K., Koike Y., and Wight T. N. (1990a) Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Puthol 137, 1253-1270.
69. Snow A. D., Wight T. N., Nochlin D., Koike Y., Kimata K., DeArmond S. J., and Prusiner S. B. (1990b) Immunolocalization of heparan sulfate proteoglycans to prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. Lab. Invest. 63, 601-611.
70. Snow A. D., Wight T. N., Mar H., Bramson R., and Kisilevsky R. (1991) A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J. Histochem. Cytochem. 40, 105-113.
71. Snow A. D., Mar H., Nochlin D., Kresse H., and Wight T. N. (1992) Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. J. Histochem. Cytochem. 40, 105-113.
72. Snow A. D., Sekiguchi R., Nochlin D., Kalaria R. N., and Kimata K. (1994a) Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not in cerebellum of Alzheimer's disease brain. Am. J. Pathol. 144, 337-347.
73. Snow A. D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mitzutani A., Arai M., Schreier W. A., and Morgan D. G. (1994b) An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar Aβ amyloid in rat brain. Neuron 12, 219-234.
74. Snow A. D., Kinsella M. G., Parks E., Sekiguchi R. T., Miller J. D., Kimata K., and Wight T. N. (1995a) Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin and versican) to the beta-amyloid protein of Alzheimer's disease. Arch. Biochem. Biophys. 320, 84-95.
75. Snow A. D., Cummings J. A., Ngo C. T., Yang W., Nochlin D., Rimvall K., Sheardown M. J., and Judge M. (1995b) Further studies implicating the importance of perlecan (a specific heparan sulfate proteoglycan) in an animal model of fibrillar Aβ amyloid deposition in vivo: comparison of Aβ (1-42) versus Aβ (1-40). Soc. Neurosci. Abstr. 21, 1282.
76. Snow A. D., Nochlin D., Sekiguchi R., and Carlson S. S. (1996) Identification and immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease. Exp. Neurol. 138, 305-317.
77. Strittmatter W. J. and Roses A. D. (1995) Apolipoprotein E and Alzheimer disease. Proc. Natl. Acad. Sci. USA 92, 4725-4727.
78. Strittmatter W. J., Saunders A. M., Goedert M., Weisgraber K. H., Dong L. M., Jakes R., Huang D. Y., Pericak Vance M., Schmechel D., and Roses A. D. (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 11183-11186.
79. Su J. H., Cummings B. J., and Cotman C. W. (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience 51, 801-813.
80. Terry R. D., Peck A., DeTeresa R., Schecter R., and Horoupian D. S. (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann. Neurol. 10, 184-192.
81. Tooyama I., Akiyama H., McGeer P. L., Hara Y., Yasuhara D., and Kimura H. (1991) Acidic fibroblast growth factor-like immunoreactivity in brain of Alzheimer's disease patients. Neurosci. Lett. 121, 155-158.
82. Van Gool D., David G., Lammens M., Baro F., and Dom R. (1993) Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia. Dementia 4, 308-314.
83. West M. J., Coleman P. D., Flood D. G., and Troncoso J. C. (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344, 769-772.
84. Wight T. N. (1995) The extracellular matrix and atherosclerosis. Curr. Opin. Lipidol. 6, 326-334.
85. Wintle R. F., Kisilevsky R., Noonan D., and Duncan A. M. V. (1990) In situ hybridization to human chromosome 1 of a cDNA probe for the gene encoding the basement membrane heparan sulfate proteoglycan (HSPG). Cytogenet. Cell Genet. 54, 60-61.
86. Young I. D., Ailles L., Narindrasorasak S., Tan R., and Kisilevsky R. (1992) Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus. Arch. Pathol. Lab. Med. 116, 951-954.